Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain
Pancreatology · 2024
DOI: 10.1016/j.pan.2024.09.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Jami L Saloman und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, University of Pittsburgh, PA, United States; Pitt…. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, University of Pittsburgh, PA, United States; Pittsburgh Center for Pain Research, School of Medicine, University of Pit…
- Department of Biostatistics, M.D. Anderson Cancer Center, Houston, TX, United States.
- Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, University of Pittsburgh, PA, United States.
- Digestive and Liver Disorders, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
- Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
Förderung
- NIDDK NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Saloman, J. L., Jennings, K., Stello, K., Li, S., Evans Phillips, A., Hall, K., Fogel, E. L., Vege, S. S., Andersen, D. K., Fisher, W. E., Forsmark, C. E., Hart, P. A., Pandol, S. J., Park, W. G., Topazian, M. D., Van Den Eeden, S. K., Serrano, J., Conwell, D. L., Li, L., …, & Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) (2024). Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain. Pancreatology. https://doi.org/10.1016/j.pan.2024.09.016
Vancouver
Saloman JL, Jennings K, Stello K, Li S, Evans Phillips A, Hall K, et al. Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain. Pancreatology. 2024. doi:10.1016/j.pan.2024.09.016
BibTeX
@article{Saloman2024,
author = {Saloman, Jami L and Jennings, Kristofer and Stello, Kimberly and Li, Shuang and Evans Phillips, Anna and Hall, Kristen and Fogel, Evan L and Vege, Santhi Swaroop and Andersen, Dana K and Fisher, William E and Forsmark, Christopher E and Hart, Phil A and Pandol, Stephen J and Park, Walter G and Topazian, Mark D and Van Den Eeden, Stephen K and Serrano, Jose and Conwell, Darwin L and Li, Liang and Yadav, Dhiraj and Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC), Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)},
title = {Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain},
journal = {Pancreatology},
year = {2024},
doi = {10.1016/j.pan.2024.09.016}
}
EUVIMED